MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) has participated in 1 clinical trials.
Therapeutic areas: Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.
Sponsors: Deciphera Pharmaceuticals, LLC.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) has 1 clinical trials on record. Their work covers Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers.
MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.